2009
DOI: 10.1177/0145721709355835
|View full text |Cite
|
Sign up to set email alerts
|

Continuous Glucose Monitoring

Abstract: Purpose-The purpose of this descriptive study was to document the experience of wearing a continuous glucose monitoring (CGM) device in women with type 2 diabetes (T2DM). The availability of CGM has provided patients and clinicians with the opportunity to describe the immediate effects of diet, exercise, and medications on blood glucose levels; however, there are few data examining patients' experiences and acceptability of using CGM.Methods-Thirty-five women with T2DM wore a CGM for 3 days. Semistructured int… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
13
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 9 publications
3
13
0
Order By: Relevance
“…One study 15 showed improved QOL and treatment satisfaction in patients switching from injections to CSII, but no effect in patients previously taking oral hypoglycemic agents (OHAs) only; another study 16 reported no overall QOL differences for CSII versus MDI. Other treatment advances such as inhaled insulin, 17, 18 continuous glucose monitoring, 19-21 continuous intraperitoneal insulin infusion, 22 pancreatic-kidney 23 and islet cell 24 transplantation, and supplemental metformin therapy 25 in T1DM, have demonstrated positive QOL impacts, but small numbers of studies and observational designs prohibit any firm conclusions.…”
Section: Resultsmentioning
confidence: 99%
“…One study 15 showed improved QOL and treatment satisfaction in patients switching from injections to CSII, but no effect in patients previously taking oral hypoglycemic agents (OHAs) only; another study 16 reported no overall QOL differences for CSII versus MDI. Other treatment advances such as inhaled insulin, 17, 18 continuous glucose monitoring, 19-21 continuous intraperitoneal insulin infusion, 22 pancreatic-kidney 23 and islet cell 24 transplantation, and supplemental metformin therapy 25 in T1DM, have demonstrated positive QOL impacts, but small numbers of studies and observational designs prohibit any firm conclusions.…”
Section: Resultsmentioning
confidence: 99%
“…53 The subjects in the CGM substudy were blinded to the real-time glucose readings, so they did not see their blood glucose results and thus did not experience the emotions that accompany seeing blood glucose values rise and fall within short time periods. The subjects were asked to calibrate their CGM monitors by performing fingerstick home blood glucose checks four times daily.…”
Section: Discussionmentioning
confidence: 99%
“…Small trials of participants with type 1 diabetes have shown that classroom education using simulated glucose curves positively affects knowledge [13], the frequency of hypoglycemic events [14], and hemoglobin A1c [14]. In T2DM, interviews with individuals before and after viewing their own glucose curves suggest that viewing the curves appears to provide individuals with a greater understanding of the daily variation in glucose (particularly postprandial peaks) and may result in greater intention to perform self-care activities, including to be more physically active [15]. We believe glucose curves offer value because they provide contextual information that individual self-monitored glucose values do not provide.…”
Section: Introductionmentioning
confidence: 99%